TipRanks
Go Ultimate55% OFF

Adaptive Biotechnologies (ADPT) Stock Forecast & Price Target

1,089 Followers
See the Price Targets and Ratings of:

ADPT Analyst Ratings

Strong Buy
8Ratings
7Buy1Hold0Sell
Based on 8 analysts giving stock ratings to Adaptive Biotechnologies in the past 3 months

ADPT Stock 12 Month Forecast

$31.07▲(20.43% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months. The average price target is $31.07 with a high forecast of $35.00 and a low forecast of $27.00. The average price target represents a 20.43% change from the last price of $25.80.
Highest Price Target$35.00Average Price Target$31.07Lowest Price Target$27.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ADPT
Price TargetFollowArticle
J.P. Morgan$27→$30buy16.28%UpsideReiterated10/14/26
TD Cowen$28→$32buy24.03%UpsideReiterated10/13/26
Morgan Stanley$22→$27hold4.65%UpsideReiterated10/13/26
Guggenheim$25→$32buy24.03%UpsideReiterated10/01/26
Goldman Sachs$35buy35.66%UpsideInitiated09/29/26
BTIG$25→$34buy31.78%UpsideReiterated09/22/26
Craig-Hallum―buy―Reiterated09/17/26
Piper Sandler$27.50buy6.59%UpsideReiterated08/24/26
William Blair―buy―Reiterated07/30/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Adaptive Biotechnologies

3 Months
Success Rate13/17 ratings generated profit
76%
Average Return
+12.86%

Copying Daniel Brennan's trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +12.86% per trade.

1 Year
Success Rate16/17 ratings generated profit
94%
Average Return
+71.91%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 94.12% of your transactions generating a profit, with an average return of +71.91% per trade.

2 Years
Success Rate16/17 ratings generated profit
94%
Average Return
+166.16%

Copying Daniel Brennan's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +166.16% per trade.

ADPT Analyst Recommendation Trends

010203040Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for ADPT
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy11000
Buy91813148
Hold13222
Sell00000
Strong Sell00000
total1122151610

In the current month, ADPT has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ADPT average Analyst price target in the past 3 months is 31.07.

ADPT Financial Forecast

$-2$-1.25$-0.5$0.25$1Q1 2026Q3 2026Q4 2026
High$-0.04
Consensus$-0.07
Low$-0.08

ADPT Earnings Forecast

Next quarter’s earnings estimate for ADPT is -$0.07 with a range of -$0.08 to -$0.04. The previous quarter’s EPS was $0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$70.9M$74.1M$77.4M$80.6M$83.9MQ1 2026Q3 2026Q4 2026
High$82.7M
Consensus$79.3M
Low$77.3M

ADPT Sales Forecast

Next quarter’s sales forecast for ADPT is $79.26M with a range of $77.30M to $82.72M. The previous quarter’s sales results were $83.90M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ADPT Stock Forecast FAQ

What is ADPT’s average 12-month price target, according to analysts?
Based on analyst ratings, Adaptive Biotechnologies’s 12-month average price target is $31.07.
What is ADPT’s upside potential, based on the analysts’ average price target?
Adaptive Biotechnologies has 20.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ADPT a Buy, Sell or Hold?
Adaptive Biotechnologies has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Adaptive Biotechnologies’s price target?
The average price target for Adaptive Biotechnologies is $31.07. This is based on 8 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.00, the lowest forecast is $27.00. The average price target represents a 20.43% increase from the current price of $25.8.
What do analysts say about Adaptive Biotechnologies?
Adaptive Biotechnologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of ADPT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.